We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




New Method Rapidly Diagnoses CVD Risk Via Molecular Blood Screening

By LabMedica International staff writers
Posted on 21 Mar 2025

Lipoproteins play a crucial role in cardiovascular health, with their composition and concentration closely linked to the risk of cardiovascular disease (CVD). More...

They are also associated with a range of other medical conditions, including diabetes and obesity. Current clinical methods for lipoprotein profiling mainly focus on a limited set of blood markers, primarily aimed at assessing cardiovascular diseases. While nuclear magnetic resonance (NMR) techniques offer a more detailed analysis of lipoproteins, they require high-field NMR spectrometers and specialized facilities, which are costly and often not available in clinical settings. Now, a pioneering study has successfully adapted high-field NMR spectroscopy-based lipoprotein analysis for use with more affordable and user-friendly benchtop NMR systems, making high-throughput CVD risk assessments more accessible in clinics and laboratories globally.

This groundbreaking study, conducted by an international team of researchers from the Australian National Phenome Centre (ANPC) at Murdoch University (Murdoch, Australia) and other collaborating institutions, was published in Analytical Chemistry. The team developed a calibration model that enables benchtop NMR spectrometers (operating at 80 MHz) to accurately quantify 25 critical lipoprotein markers, including total cholesterol, LDL-C, HDL-C, ApoA1, and ApoB100, in under 15 minutes per sample. These markers are vital for assessing cardiometabolic risk and monitoring inflammatory conditions, providing clinicians with a quick and reliable diagnostic tool. One of the significant accomplishments of the study was demonstrating the reproducibility of results across three independent laboratories, validating the robustness of the technology.

The ability to conduct precise lipoprotein analysis using compact and easy-to-maintain instruments represents a shift in preventive medicine. The affordability and accessibility of benchtop NMR technology could revolutionize cardiovascular disease screening, particularly in resource-constrained environments or in geographically expansive regions with dispersed populations, such as Western Australia, where centralized testing facilities may be hundreds of kilometers away from rural communities. Beyond CVD risk assessment, this technology could also be applied to diabetes management, chronic inflammatory disease monitoring, and even infectious disease diagnosis, building on the ANPC’s discovery of new biomarkers for active viral infections. The researchers plan to continue refining the benchtop NMR model, expanding its capabilities to support a wider range of clinical applications. Ongoing research will also investigate its potential in tracking disease progression and treatment responses using micro-sampling strategies, further cementing the role of NMR-based diagnostics in modern healthcare.

“Currently most CVD risk markers are only measured on high-risk patients, and it would be much better to detect these markers earlier to enable corrective action,” said ANPC Director and co-study lead Professor Jeremy Nicholson. “This new approach will also allow us to study the general population at scale for the first time.”

“By eliminating the barriers associated with high-field NMR, we are enabling broader access to detailed lipid profiling, which could significantly improve early detection and management of cardiovascular and metabolic diseases,” added Dr. Philipp Nitschke, a contributing researcher to the study.

Related Links:
ANPC


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Serological Pipet Controller
PIPETBOY GENIUS
New
Enterovirus Test
Quanty Enterovirus System
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New automated lab procedures can detect opioids in tiny amounts of blood (Photo courtesy of Tripathi Lab/Brown University)

First-Of-Its-Kind Quantitative Method Assesses Opioid Exposure in Newborns

As the opioid crisis continues to impact communities across the United States, laboratories encounter significant difficulties in accurately detecting opioid substances in individuals with opioid use disorder.... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: T cell immunity could be a marker for early Parkinson’s treatment (Photo courtesy of Shutterstock)

T Cells in Blood Can Detect Parkinson's Years Before Diagnosis

Diagnosing Parkinson’s disease before the appearance of motor symptoms remains one of neurology’s most significant challenges. Patients can go years—even decades—without a diagnosis, as subtle early indicators... Read more

Microbiology

view channel
Image: A prototype of the lateral flow test (Photo courtesy of University of Exeter)

POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques

Diagnosing mucormycosis—an aggressive and often deadly fungal infection—remains a major challenge due to the disease’s rapid progression and the lack of fast, accurate diagnostic tools. The problem became... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.